Richard John Wallace - 07 Nov 2023 Form 4 Insider Report for ImmunoGen, Inc.

Role
Director
Signature
/s/ Renee Lentini, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
07 Nov 2023
Net transactions value
+$147,000
Form type
4
Filing time
08 Nov 2023, 17:53:58 UTC
Previous filing
16 Jun 2023
Next filing
12 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMGN Common Stock Options Exercise $147,000 +10,000 $14.70 10,000 07 Nov 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMGN Stock Option (Right to Buy) Options Exercise $0 -10,000 -100% $0.000000* 0 07 Nov 2023 Common Stock 10,000 $14.70 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on 11/12/2013 and is fully vested as of the transaction date.